Earnings Per Share
Alnylam Pharmaceuticals·Income Statement·4 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Weighted-average shares, diluted | 126.7M | 128.6M | 127.7M | 129.7M | 130.6M | 137.3M | 134.7M | 138.2M |
| Weighted-average shares, basic | 126.7M | 128.6M | 127.7M | 129.7M | 130.6M | 131.4M | 131M | 132.9M |
| Basic earnings per share | $-0.13 | $-0.87 | $-0.65 | $-0.14 | $-0.51 | $1.91 | $0.84 | $1.55 |
| Diluted earnings per share | $-0.13 | $-0.87 | $-0.65 | $-0.14 | $-0.51 | $1.84 | $0.82 | $1.51 |